Animal Biotechnology Market Size, Share & Trends Analysis Report By Product (Diagnostics Tests, Biologics, Drugs, Reproductive & Genetic, Nutrition), By Application, By Animal Type (Livestock, Companion), By End-use, By Region, And Segment Forecasts, 2025 - 2030
Aloe Vera Drinks Market Growth & Trends
The global aloe vera drinks market size is expected to reach USD 254.83 million by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 11.7% from 2025 to 2030. Rising demand for healthy, nutritious, and ready-to-drink products among all age groups across the globe is the key factor for the market growth. Moreover, these drinks have excellent medicinal properties and can treat various skin and liver-related diseases. These medicinal properties of the product are also offering new scope for the global market.
Rising health consciousness among consumers owing to busy, stressful, and hectic lifestyles is fueling the demand for nutritious and healthy plant-derived drinks, such as aloe vera-based drinks. Moreover, shifting consumer predilection for healthy plant-derived drinks rather than high calorie and sugary carbonated drinks are offering lucrative growth opportunities for the market. These consumer trends are anticipated to boost demand in the global market. In addition, the product has excellent medicinal properties, which help to improve liver functioning, and is an excellent source of vitamins and minerals, like vitamins B, C, E, and folic acid.
Asia Pacific was the largest regional market, accounting for a share of more than 30.0% in 2019. Aloe-based juice or drink is a traditional drink, which is widely consumed in various countries, such as India, China, South Korea, and Japan, owing to its excellent medicinal properties. With the increasing popularity of healthy plant-based beverages among the young generation and working-class population, the demand for aloe vera drinks is anticipated to grow in the region over the forecast period.
Aloe Vera Drinks Market Report Highlights
- Based on products, the unflavored segment dominated the global aloe vera drinks industry with a revenue share of 62.6% in 2024.
- Flavored aloe vera drinks are projected to experience the highest CAGR from 2025 to 2030.
- Hypermarkets & supermarkets dominated the global aloe vera industry with the highest revenue share in 2024.
- The online distribution segment is projected to experience the fastest CAGR from 2025 to 2030.
- Asia Pacific aloe vera drinks market dominated the global industry with a revenue share of 32.7% in 2024.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR’s Internal Database
- 1.3.3. Secondary Sources
- 1.3.4. Primary Research
- 1.4. Information/Data Analysis
- 1.5. Market Formulation & Visualization
- 1.6. Data Validation & Publishing
- 1.7. Model Details
- 1.7.1. Commodity flow analysis
- 1.7.2. Global Market: CAGR Calculation
- 1.8. List of Secondary Sources
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- Chapter 3. Animal Biotechnology Market Variable Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market
- 3.1.2. Ancillary Market
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising R&D initiatives
- 3.2.1.2. Rising Prevalence of Different Diseases in Animals
- 3.2.1.3. Increasing Regulatory Control
- 3.2.1.4. Support Initiatives by Industry Participants
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Technology limitations in under-developed regions
- 3.2.2.2. Limited Resources & Funding
- 3.2.2.3. Ethical Concerns
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.3. Animal Biotechnology Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitution
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal Landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental Landscape
- 3.3.3. Regulatory Framework
- 3.3.4. Estimated Animal Population, by Key Countries and Key Species, 2018-2023
- 3.3.5. Product Pricing Analysis
- 3.3.6. COVID-19 Impact Analysis
- Chapter 4. Animal Biotechnology Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Animal Biotechnology Market Product Movement Analysis
- 4.3. Animal Biotechnology Market Size & Trend Analysis, By Product, 2018 - 2030 (USD Million)
- 4.3.1. Diagnostics
- 4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.3.2. Biologics
- 4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.3.3. Drugs
- 4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.3.4. Reproductive And Genetic
- 4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.3.5. Nutrition
- 4.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 5. Animal Biotechnology Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Animal Biotechnology Market Application Movement Analysis
- 5.3. Animal Biotechnology Market Size & Trend Analysis, By Application, 2018 - 2030 (USD Million)
- 5.3.1. Diagnosis of Animal Diseases
- 5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.3.2. Treatment of Animal Diseases
- 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.3.3. Preventive Care of Animals
- 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.3.4. Product Research & Development
- 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.3.5. Other Applications
- 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 6. Animal Biotechnology Market: Animal Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Animal Biotechnology Market Animal Movement Analysis
- 6.3. Animal Biotechnology Market Size & Trend Analysis, By Animal, 2018 - 2030 (USD Million)
- 6.3.1. Livestock
- 6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.1.2. Poultry
- 6.3.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.1.3. Swine
- 6.3.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.1.4. Cattle
- 6.3.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.1.5. Sheep & Goats
- 6.3.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.1.6. Fish
- 6.3.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.2. Companion
- 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.2.2. Dogs
- 6.3.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.2.3. Cats
- 6.3.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.2.4. Horses
- 6.3.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.2.5. Other Companion
- 6.3.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 7. Animal Biotechnology Market: End Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Animal Biotechnology Market End Use Movement Analysis
- 7.3. Animal Biotechnology Market Size & Trend Analysis, By End Use, 2018 - 2030 (USD Million)
- 7.3.1. Laboratories
- 7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.2. Point-of-care testing/In-house testing
- 7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.3. Veterinary Hospitals & Clinics
- 7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.4. Other end use
- Chapter 8. Animal Biotechnology Market: Country Estimates & Trend Analysis, by product, application, animal, & end use
- 8.1. Regional Dashboard
- 8.2. Animal Biotechnology Market Share, By Region, 2023 & 2030 USD Million
- 8.3. Regional Outlook
- 8.4. North America
- 8.4.1. North America Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.4.2. U.S.
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competition Insights
- 8.4.2.3. U.S. Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. Canada
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competition Insights
- 8.4.3.3. Canada Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. Mexico
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competition Insights
- 8.4.4.3. Mexico Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5. Europe
- 8.5.1. Europe Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. UK
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competition Insights
- 8.5.2.3. UK Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Germany
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competition Insights
- 8.5.3.3. Germany Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.4. France
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Competition Insights
- 8.5.4.3. France Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.5. Italy
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. Competition Insights
- 8.5.5.3. Italy Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.6. Spain
- 8.5.6.1. Key Country Dynamics
- 8.5.6.2. Competition Insights
- 8.5.6.3. Spain Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.7. Denmark
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Competition Insights
- 8.5.7.3. Denmark Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.8. Sweden
- 8.5.8.1. Key Country Dynamics
- 8.5.8.2. Competition Insights
- 8.5.8.3. Sweden Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.9. Norway
- 8.5.9.1. Key Country Dynamics
- 8.5.9.2. Competition Insights
- 8.5.9.3. Norway Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6. Asia Pacific
- 8.6.1. Asia Pacific Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. Japan
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competition Insights
- 8.6.2.3. Japan Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. China
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competition Insights
- 8.6.3.3. China Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. India
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Competition Insights
- 8.6.4.3. India Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. Australia
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Competition Insights
- 8.6.5.3. Australia Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.6. South Korea
- 8.6.6.1. Key Country Dynamics
- 8.6.6.2. Competition Insights
- 8.6.6.3. South Korea Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.7. Thailand
- 8.6.7.1. Key Country Dynamics
- 8.6.7.2. Competition Insights
- 8.6.7.3. Thailand Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.7. Latin America
- 8.7.1. Latin America Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.7.2. Brazil
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Competition Insights
- 8.7.2.3. Brazil Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030
- 8.7.3. Argentina
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Competition Insights
- 8.7.3.3. Argentina Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.8. Middle East & Africa
- 8.8.1. Middle East & Africa Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.8.2. South Africa
- 8.8.2.1. Key Country Dynamics
- 8.8.2.2. Competition Insights
- 8.8.2.3. South Africa Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.8.3. Saudi Arabia
- 8.8.3.1. Key Country Dynamics
- 8.8.3.2. Competition Insights
- 8.8.3.3. Saudi Arabia Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.8.4. UAE
- 8.8.4.1. Key Country Dynamics
- 8.8.4.2. Competition Insights
- 8.8.4.3. UAE Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.8.5. Kuwait
- 8.8.5.1. Key Country Dynamics
- 8.8.5.2. Competition Insights
- 8.8.5.3. Kuwait Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- Chapter 9. Competitive Landscape
- 9.1. Market Participant Categorization
- 9.2. Participants Overview
- 9.3. Financial Performance
- 9.4. Product Benchmarking
- 9.5. Market Position Analysis, 2023 (Heat Map Analysis)
- 9.6. Strategy Mapping
- 9.6.1. Mergers And Acquisitions
- 9.6.2. Launch
- 9.6.3. Partnerships & Collaborations
- 9.6.4. Expansion
- 9.6.5. Others
- 9.7. Company Profiles
- 9.7.1. Zoetis
- 9.7.1.1. Participant’s overview
- 9.7.1.2. Financial performance
- 9.7.1.3. Product Benchmarking
- 9.7.1.4. Strategic initiatives
- 9.7.2. Boehringer Ingelheim
- 9.7.2.1. Participant’s overview
- 9.7.2.2. Financial performance
- 9.7.2.3. Product Benchmarking
- 9.7.2.4. Strategic initiatives
- 9.7.3. Merck & Co. Inc.
- 9.7.3.1. Participant’s overview
- 9.7.3.2. Financial performance
- 9.7.3.3. Product Benchmarking
- 9.7.3.4. Strategic initiatives
- 9.7.4. Virbac
- 9.7.4.1. Participant’s overview
- 9.7.4.2. Financial performance
- 9.7.4.3. Product Benchmarking
- 9.7.4.4. Strategic initiatives
- 9.7.5. Elanco
- 9.7.5.1. Participant’s overview
- 9.7.5.2. Financial performance
- 9.7.5.3. Product Benchmarking
- 9.7.5.4. Strategic initiatives
- 9.7.6. Idexx Laboratories
- 9.7.6.1. Participant’s overview
- 9.7.6.2. Financial performance
- 9.7.6.3. Product Benchmarking
- 9.7.6.4. Strategic initiatives
- 9.7.7. Dechra Pharmaceuticals
- 9.7.7.1. Participant’s overview
- 9.7.7.2. Financial performance
- 9.7.7.3. Product Benchmarking
- 9.7.7.4. Strategic initiatives
- 9.7.8. Heska Corporation
- 9.7.8.1. Participant’s overview
- 9.7.8.2. Financial performance
- 9.7.8.3. Product Benchmarking
- 9.7.8.4. Strategic initiatives
- 9.7.9. Indian Immunologicals Ltd.
- 9.7.9.1. Participant’s overview
- 9.7.9.2. Financial performance
- 9.7.9.3. Product Benchmarking
- 9.7.9.4. Strategic initiatives
- 9.7.10. Hester Biosciences Pvt. Ltd.
- 9.7.10.1. Participant’s overview
- 9.7.10.2. Financial performance
- 9.7.10.3. Product Benchmarking
- 9.7.10.4. Strategic initiatives
- 9.7.11. Biogénesis Bagó
- 9.7.11.1. Participant’s overview
- 9.7.11.2. Financial performance
- 9.7.11.3. Product Benchmarking
- 9.7.11.4. Strategic initiatives
- 9.8. List of Other Market Players
- Chapter 10. Key Takeaways
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook